- Home
- GLBS vs INMB Comparison
GLBS vs INMB Comparison
Compare GLBS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLBS | INMB |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7M | 40.4M |
| IPO Year | 2010 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GLBS | INMB |
|---|---|---|
| Price | $2.17 | $1.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.00 | ★ $5.40 |
| AVG Volume (30 Days) | 55.9K | ★ 220.1K |
| Earning Date | 06-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | $13.06 | N/A |
| Revenue Next Year | $20.20 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $1.00 | $1.09 |
| 52 Week High | $2.44 | $11.64 |
Technical Indicators
Market Signals| Indicator | GLBS | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 50.73 |
| Support Level | $1.51 | $1.38 |
| Resistance Level | $2.23 | $1.48 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 41.46 | 35.85 |
Price Performance
Historical ComparisonAbout GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.